Showing results (71-80 of 191) with videos related to

Sort By:
Pageof 20
Blood Cancer Discovery|November 15, 2021
Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid LeukemiaJoshua F Zeidner, Benjamin G Vincent, Anastasia Ivanova, et al.
European Journal of Immunology|April 23, 2014
Altered T-cell entry and egress in the absence of Coronin 1A attenuates murine acute graft versus host diseaseLeShara M Fulton, Nicholas A Taylor, James M Coghill, et al.
Nature Machine Intelligence|September 29, 2025
Conditional generation of real antigen-specific T cell receptor sequencesDhuvarakesh Karthikeyan, Sarah N Bennett, Amy G Reynolds, et al.
Blood|August 5, 2004
L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejectionPatricia A Taylor, Angela Panoskaltsis-Mortari, Jessica M Swedin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2012
Attenuation of acute graft-versus-host disease in the absence of the transcription factor RORγtLeShara M Fulton, Michael J Carlson, James M Coghill, et al.
EMBO Molecular Medicine|January 9, 2026
Pathobiology and clinical significance of malignant pleural effusionsAllison T Woods, Abner A Murray, Benjamin G Vincent, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2003
An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignanciesThomas C Shea, Rebecca Bruner, Joseph M Wiley, et al.
Cancer Discovery|December 3, 2017
Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human CancersOliver M T Pearce, Robin M Delaine-Smith, Eleni Maniati, et al.
Pageof 20